Inception Therapeutics is a multi-disciplinary discovery engine founded in 2011 with Versant Ventures to build and launch transformative new biotechnology companies. Inception’s integrated chemistry, biology and DMPK expertise and capabilities coupled with a successful track record have enabled Inception to become an established leader in new company creation.

Executive Leadership

Richard Glynne photo

Richard Glynne, Ph.D.
President & Chief Scientific Officer

Don Hertzog photo

Don Hertzog
Vice President, Head of Chemistry

rich van doren photo

Rich Van Doren
Chief Financial Officer

cathy dring photo

Cathy Dring
General Counsel

Board of Directors

Tom Woiwode photo

Tom Woiwode, Ph.D.​
Board of Directors

Benjamin Cravatt photo

Benjamin F. Cravatt
Board of Directors

Tom Daniel photo

Tom Daniel
Board of Directors

Richard Glynne photo

Richard Glynne, Ph.D.
President & Chief Scientific Officer

Scientific Advisory Board

Carolyn Bertozzi photo

Carolyn Bertozzi
Scientific Advisor

Benjamin Cravatt photo

Benjamin F. Cravatt
Scientific Advisor

Nathanael Gray photo

Nathanael S. Gray, Ph.D.
Scientific Advisor

Sean Morrison photo

Sean Morrison
Scientific Advisor

James Wells photo

James A. Wells, Ph.D.
Scientific Advisor